HomeTagsFDA approval

FDA approval

Travere Therapeutics Announces FDA Accelerated Approval of FILSPARI™ (sparsentan), the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA Nephropathy

DTN - February 18, 2023

There’s a new Botox competitor, and studies suggest the effects last longer. Here’s how it works.

DTN - September 15, 2022